203 related articles for article (PubMed ID: 24999657)
1. Suppression of La antigen exerts potential antiviral effects against hepatitis A virus.
Jiang X; Kanda T; Wu S; Nakamoto S; Saito K; Shirasawa H; Kiyohara T; Ishii K; Wakita T; Okamoto H; Yokosuka O
PLoS One; 2014; 9(7):e101993. PubMed ID: 24999657
[TBL] [Abstract][Full Text] [Related]
2. Suppression of hepatitis A virus genome translation and replication by siRNAs targeting the internal ribosomal entry site.
Kanda T; Zhang B; Kusov Y; Yokosuka O; Gauss-Müller V
Biochem Biophys Res Commun; 2005 May; 330(4):1217-23. PubMed ID: 15823573
[TBL] [Abstract][Full Text] [Related]
3. La autoantigen suppresses IRES-dependent translation of the hepatitis A virus.
Cordes S; Kusov Y; Heise T; Gauss-Müller V
Biochem Biophys Res Commun; 2008 Apr; 368(4):1014-9. PubMed ID: 18282467
[TBL] [Abstract][Full Text] [Related]
4. The JAK2 inhibitor AZD1480 inhibits hepatitis A virus replication in Huh7 cells.
Jiang X; Kanda T; Nakamoto S; Saito K; Nakamura M; Wu S; Haga Y; Sasaki R; Sakamoto N; Shirasawa H; Okamoto H; Yokosuka O
Biochem Biophys Res Commun; 2015 Mar; 458(4):908-12. PubMed ID: 25704089
[TBL] [Abstract][Full Text] [Related]
5. Drug Screening for Hepatitis A Virus (HAV): Nicotinamide Inhibits c-Jun Expression and HAV Replication.
Sasaki-Tanaka R; Masuzaki R; Okamoto H; Shibata T; Moriyama M; Kogure H; Kanda T
J Virol; 2023 Feb; 97(2):e0198722. PubMed ID: 36728416
[TBL] [Abstract][Full Text] [Related]
6. The sirtuin inhibitor sirtinol inhibits hepatitis A virus (HAV) replication by inhibiting HAV internal ribosomal entry site activity.
Kanda T; Sasaki R; Nakamoto S; Haga Y; Nakamura M; Shirasawa H; Okamoto H; Yokosuka O
Biochem Biophys Res Commun; 2015 Oct; 466(3):567-71. PubMed ID: 26388050
[TBL] [Abstract][Full Text] [Related]
7. Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus.
Kanda T; Nakamoto S; Wu S; Nakamura M; Jiang X; Haga Y; Sasaki R; Yokosuka O
J Clin Transl Hepatol; 2015 Sep; 3(3):205-10. PubMed ID: 26623267
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects on HAV IRES-mediated translation and replication by a combination of amantadine and interferon-alpha.
Yang L; Kiyohara T; Kanda T; Imazeki F; Fujiwara K; Gauss-Müller V; Ishii K; Wakita T; Yokosuka O
Virol J; 2010 Sep; 7():212. PubMed ID: 20815893
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-29 suppresses hepatitis A and C viral internal ribosomal entry site-mediated translation.
Kanda T; Wu S; Kiyohara T; Nakamoto S; Jiang X; Miyamura T; Imazeki F; Ishii K; Wakita T; Yokosuka O
Viral Immunol; 2012 Oct; 25(5):379-86. PubMed ID: 23035851
[TBL] [Abstract][Full Text] [Related]
10. [siRNAs targeting La, hVAP-33, eIF2Bgamma, and HCV IRES inhibit the replication and expression of HCV in Huh7 cells].
Wang MX; Xu B; Duan J; Fu XQ; Jin M
Zhonghua Gan Zang Bing Za Zhi; 2012 Oct; 20(10):769-73. PubMed ID: 23207339
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of internal ribosomal entry site-directed translation of HCV by recombinant IFN-alpha correlates with a reduced La protein.
Shimazaki T; Honda M; Kaneko S; Kobayashi K
Hepatology; 2002 Jan; 35(1):199-208. PubMed ID: 11786977
[TBL] [Abstract][Full Text] [Related]
12. Interference of hepatitis A virus replication by small interfering RNAs.
Kanda T; Kusov Y; Yokosuka O; Gauss-Müller V
Biochem Biophys Res Commun; 2004 May; 318(2):341-5. PubMed ID: 15120607
[TBL] [Abstract][Full Text] [Related]
13. Amantadine inhibits hepatitis A virus internal ribosomal entry site-mediated translation in human hepatoma cells.
Kanda T; Yokosuka O; Imazeki F; Fujiwara K; Nagao K; Saisho H
Biochem Biophys Res Commun; 2005 Jun; 331(2):621-9. PubMed ID: 15850805
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis A virus (HAV) proteinase 3C inhibits HAV IRES-dependent translation and cleaves the polypyrimidine tract-binding protein.
Kanda T; Gauss-Müller V; Cordes S; Tamura R; Okitsu K; Shuang W; Nakamoto S; Fujiwara K; Imazeki F; Yokosuka O
J Viral Hepat; 2010 Sep; 17(9):618-23. PubMed ID: 19889140
[TBL] [Abstract][Full Text] [Related]
15. La Autoantigen Induces Ribosome Binding Protein 1 (RRBP1) Expression through Internal Ribosome Entry Site (IRES)-Mediated Translation during Cellular Stress Condition.
Gao W; Li Q; Zhu R; Jin J
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27447629
[TBL] [Abstract][Full Text] [Related]
16. In vitro characterization of an internal ribosomal entry site (IRES) present within the 5' nontranslated region of hepatitis A virus RNA: comparison with the IRES of encephalomyocarditis virus.
Brown EA; Zajac AJ; Lemon SM
J Virol; 1994 Feb; 68(2):1066-74. PubMed ID: 8289336
[TBL] [Abstract][Full Text] [Related]
17. Molecular biology and inhibitors of hepatitis A virus.
Debing Y; Neyts J; Thibaut HJ
Med Res Rev; 2014 Sep; 34(5):895-917. PubMed ID: 23722879
[TBL] [Abstract][Full Text] [Related]
18. Novel perspectives for hepatitis A virus therapy revealed by comparative analysis of hepatitis C virus and hepatitis A virus RNA replication.
Esser-Nobis K; Harak C; Schult P; Kusov Y; Lohmann V
Hepatology; 2015 Aug; 62(2):397-408. PubMed ID: 25866017
[TBL] [Abstract][Full Text] [Related]
19. La protein required for internal ribosome entry site-directed translation is a potential therapeutic target for hepatitis C virus replication.
Shirasaki T; Honda M; Mizuno H; Shimakami T; Okada H; Sakai Y; Murakami S; Wakita T; Kaneko S
J Infect Dis; 2010 Jul; 202(1):75-85. PubMed ID: 20497049
[TBL] [Abstract][Full Text] [Related]
20. A small yeast RNA blocks hepatitis C virus internal ribosome entry site (HCV IRES)-mediated translation and inhibits replication of a chimeric poliovirus under translational control of the HCV IRES element.
Das S; Ott M; Yamane A; Tsai W; Gromeier M; Lahser F; Gupta S; Dasgupta A
J Virol; 1998 Jul; 72(7):5638-47. PubMed ID: 9621022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
